Associate Director, US HCC Strategy Lead – HIV Alliance
MSD
About this role
The Associate Director, US HCC Strategy Lead will develop and lead patient-centric healthcare consumer (HCC) strategy for an investigational once-weekly HIV treatment developed through an alliance. The role ensures the voice of people living with HIV guides commercial planning and omnichannel engagement, and partners with global and alliance stakeholders to maximize commercial value. The position reports to the Director, U.S. Commercial Leader and works cross-functionally to align HCC initiatives.
Skills
Qualifications
About MSD
msd.comAt MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Recent company news
MSD reaffirms long-term commitment to Vietnam's healthcare sector
3 hours ago
ASCO GU: How Merck & Co/MSD is Advancing Treatment of Bladder and Kidney Cancers
3 weeks ago
Louisville Water Company, MSD honor 96 veterans during annual breakfast
Nov 7, 2025
MSD ends takeover talks with Revolution Medicines
1 month ago
Exclusive Interview with BDT & MSD Partners Co-CEOs
Nov 19, 2025
About MSD
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for MSD.
Salary
$142k – $224k
per year
More jobs at MSD
Similar Jobs
Director, Marketing Strategy and Planning
Gilead Sciences
Executive Director, HIV Treatment Marketing
Gilead Sciences
Director, US Medical Affairs - HIV Prevention Scientific Engagement lead - Central US
Gilead Sciences
Associate Director, HIV Franchise Marketing, HIV Speaker Bureau and Congress Strategy
Gilead Sciences
Senior Director, Marketing Strategy and Planning
Gilead Sciences
Director, US HIV Prevention (PrEP) Forecasting
Gilead Sciences